Surgical Oncology
The Department of Oncology (Oncology Center) of Tsinghua University Beijing Tsinghua Chang Gung Hospital is a modern oncology treatment center built upon the comprehensive disciplinary advantages of Tsinghua University. Adhering to Tsinghua University's motto of "Self-reliance and Perseverance, Virtue and Responsibility" and the spirit of "Diligence and Simplicity" of Chang Gung Memorial Hospital in Taiwan, it practices the service philosophy of "Patients First." The department's flagship strength lies in the comprehensive diagnosis and treatment system for peritoneal cancer, with cutting-edge precision intelligent minimally invasive surgery for gastrointestinal tumors. Its distinctive treatment approach utilizes a multidisciplinary team (MDT) model involving doctors, nurses, and patients, positioning itself as an internationally leading innovation hub for peritoneal cancer diagnosis and treatment technology and a demonstration center for precision minimally invasive surgery for gastrointestinal tumors.
Historical Origins and Spiritual Inheritance:
The Department of Oncology at Beijing Tsinghua Chang Gung Hospital was officially established in 2014, with staff including physicians and nurses. All attending physicians (and above) were transferred from renowned tertiary hospitals in Beijing, while all resident physicians graduated from Peking University School of Medicine and Peking Union Medical College, holding at least a master's degree. Most physicians and nurses have received specialized training at Chang Gung Memorial Hospital in Taiwan. The oncology center has now become a comprehensive oncology treatment center covering multiple disciplines, including peritoneal oncology, gastrointestinal surgery, medical oncology, and radiotherapy.
Core business operational efficiency:
The Department of Oncology primarily handles the diagnosis and treatment of malignant tumors such as lung cancer, breast cancer, colorectal cancer, liver cancer, and pancreatic cancer, emphasizing multidisciplinary and standardized treatment. Under the leadership of Professor Li Yan, the Department of Peritoneal Oncology has completed over 3,300 related surgeries to date, achieving internationally leading technical standards. The Gastrointestinal Oncology MDT team, led by Professor Li Guoxin, holds regular MDT discussions every Tuesday afternoon. They have established an intelligent MDT data processing system to achieve structured integration of case data, forming a specialized gastrointestinal MDT database. This provides a data foundation for comprehensive patient management, follow-up tracking, quality control, and research analysis.
Discipline Positioning and Benchmarking:
It is a core discipline of the affiliated hospital of Tsinghua University School of Clinical Medicine, a Beijing resident physician training base, and a teaching and internship base of Tsinghua University School of Medicine. The Department of Peritoneal Oncology has established the "China Center of the International Federation for Peritoneal Cancer", the "China Center of the European Academy of Peritoneal Cancer", the "Beijing Training Base for Deep Hyperthermia and Whole-body Hyperthermia Techniques for Tumors", and the "Beijing International Science and Technology Cooperation Base for New Technologies in the Diagnosis and Treatment of Peritoneal Cancer". Professor Li Yan serves as the Standing Committee Member (the only representative from China) of the Executive Committee of the International Consortium for Peritoneal Surface Tumors (POSGI). She presided over the formulation of my country's "Expert Consensus on the Treatment of Peritoneal Pseudomyxoma with Tumor Cytoreduction Combined with Intraperitoneal Hyperthermic Chemotherapy," "Expert Consensus on the Diagnosis and Treatment of Malignant Peritoneal Mesothelioma," and "Expert Consensus on the Diagnosis and Treatment of Peritoneal Cancer." She also participated in the formulation of three international guidelines or expert consensuses on the diagnosis and treatment of peritoneal cancer. Professor Li Guoxin serves as the founder of the Chinese Laparoscopic Gastrointestinal Surgery Research Group (CLASS), Chairman of the Upper Gastrointestinal Tract Committee of the Surgical Committee for Capacity Building and Continuing Education of the National Health Commission, and Vice Chairman of the Gastric Cancer Quality Control Expert Committee of the National Cancer Center.
